Lizarazo, D., Zabala, V., Tong, M., Longato, L., & de la Monte, S. M. (2013). Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis. J Gastroenterol Hepatol.
Citação norma ChicagoLizarazo, Diana, Valerie Zabala, Ming Tong, Lisa Longato, and Suzanne M. de la Monte. "Ceramide Inhibitor Myriocin Restores Insulin/insulin Growth Factor Signaling for Liver Remodeling in Experimental Alcohol-related Steatohepatitis." J Gastroenterol Hepatol 2013.
MLA引文Lizarazo, Diana, et al. "Ceramide Inhibitor Myriocin Restores Insulin/insulin Growth Factor Signaling for Liver Remodeling in Experimental Alcohol-related Steatohepatitis." J Gastroenterol Hepatol 2013.